The two halves of the formula work on different timelines, and the maximum-strength format changes the adjustment period for both.

The acne side moves on the standard acne timeline: meaningful clearing between weeks 6 and 12, with stable results over months 3 to 6 — though the adjustment period is more demanding than with a balanced-strength formula:

  • Weeks 1 to 3. Skin is adjusting to a stronger formula. Expect more pronounced dryness, peeling, and possible irritation than with a balanced-strength prescription.
  • Weeks 3 to 6. Skin may temporarily look worse before it looks better — sometimes called the purge. With a maximum-strength formula, the purge can be more visible because the formula is clearing deeper congestion faster.
  • Weeks 6 to 12. Active breakout count typically begins to drop. For resistant acne specifically, this is often the first time the underlying pattern visibly shifts.
  • Months 3 to 6. Stable clearing pattern.

The anti-aging side moves on a longer timeline. Visible improvement in deeper wrinkles, photoaging, and firmness typically appears between months 3 and 6, with continued correction over months 6 to 12. Higher-strength retinoids tend to produce more visible anti-aging changes than balanced-strength ones over the same time window, but they do not shortcut the underlying timeline — collagen response and pigment correction still take months to develop.

The honest version: in the first three months, you will mostly see the acne side of the formula working. By month six, the anti-aging side starts to become visible. This is normal and is the reason this formula is built for a longer commitment than a pure acne treatment — and one that is also more demanding on the skin in the first weeks.

If you have not seen any improvement in active breakouts by week 12, message the team. The dermatologist on your case can adjust your formula or — if your acne pattern is hormonal or cystic with deep cysts and scarring risk — recommend an in-person evaluation for oral medication.

Results vary. The timelines above describe the pattern observed in clinical use of these active categories; individual response depends on the specific case.